() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Government Changes a Big Step Forward for Toowoomba’s Medicinal Cannabis Project

Government Changes a Big Step Forward for Toowoomba’s Medicinal MJ Project

Earlier today, Federal Member for Groom John McVeigh, announced in a media release that Toowoomba’s future as a major global player in the medicinal MJ industry is a step closer, following the announcement by the Morrison Government today that from next month it will prioritise licences for medicinal MJ projects that have been granted Major Project Status.

Asterion was granted Major Project Status for its Toowoomba medicinal cannabis project in April, 2019.

Federal Member for Groom John McVeigh said the $450 million medicinal MJ proposal at Wellcamp was granted Major Project Status earlier this year, reflecting its likely impact on exports, jobs and industry development.

To read the full media release see link below.


About Asterion

Asterion is a Canadian medicinal MJ company with operations in Australia, specializing in medical MJ and is focused on becoming an industry leader in next-generation MJ products. The Company is focused on the future of advanced agriculture and aims to produce the highest quality of genetically uniform MJ strains, at an affordable price.

The Company is led by a team of highly experienced executives with over 120 years of combined experience in medical MJ, renewable energy, capital markets, and other highly relevant sectors across North America, Oceania, Europe, Africa and Asia.

On Behalf of the Board of Directors
“Stephen Van Deventer”
Chairman & Chief Executive Officer

For further information, please contact:
Deanna Kress

Forward-Looking Statements: 

This news release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995.  Other than statements of historical fact, all statements included in this news release, including, without limitation, statements regarding the Company’s anticipated business plans and prospects of success in executing its plans, are forward-looking statements that involve various risks and uncertainties.  There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements.  Various risks and uncertainties could cause actual results to differ materially from Asterion’s expectations.  Other factors such as general economic, market or business conditions, future prices of cannabis, changes in the financial markets and in the demand and market price for cannabis, or changes in laws, regulations and policies affecting the biotechnology or cannabis industry, and delays in obtaining governmental and regulatory approvals, may also adversely affect the future results or performance of the Company.  Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements.

Comments are closed.